Optibac

Optibac For Those On Antibiotics

Size
 
£7.99
 

Who is it for?

For Those On Antibiotics is for anyone looking to buy a high-quality friendly bacteria supplement developed and proven especially to be taken alongside a course of antibiotics.

Key benefits

Friendly bacteria for antibiotics

Best for anyone looking for a natural friendly bacteria supplement to take at the same time as antibiotics.

  • Suitable to take with antibiotics Extensively researched and shown to be safe to take alongside a variety of antibiotics
  • Scientifically proven to reach the gut alive Strains survive, even when taken at the same time as antibiotics
  • Highly researched friendly bacteria Contains 3 strains which have been collectively researched in over 25 scientific studies specific to antibiotic use
  • Easy to take on a daily basis Designed to be taken once daily throughout a course of antibiotics. Can also be taken for longer periods alongside long-term antibiotics
  • A more natural option This vegan and gluten free supplement has no added sweeteners or flavourings often found in other products containing live cultures
  • From the UK's most recommended brand Optibac is the brand of friendly bacteria supplements most recommended by UK consumers

Live Cultures

  • Lactobacillus rhamnosus Rosell-11
  • Bifidobacterium lactis Lafti B94
  • Lactobacillus acidophilus/helveticus Rosell-52

Ingredients

Stabiliser: potato starch; vegetarian capsule: hydroxypropyl methylcellulose; Live cultures: Lactobacillus rhamnosus Rosell-11, Bifidobacterium lactis Lafti B94, Lactobacillus acidophilus/helveticus Rosell-52; anti-caking agent: vegetable magnesium stearate; antioxidant: ascorbic acid

Each capsule guarantees 4.5 billion live cultures.

Suitability

  • Vegetarian
  • Vegan
  • No dairy
  • Gluten free
  • Yeast free
  • Suitable during pregnancy
  • Suitable during breastfeeding
  • GMO free
  • Free from artificial flavourings, colourings and preservatives
  • No chemicals or parabens
  • Sugar free

Following the taxonomic updates advised by a global team of scientists and published in April 2020, a reclassification has been proposed for the L. rhamnosus species. The L. rhamnosus strain in For Those On Antibiotics may therefore now also be known as Lacticaseibacillus rhamnosus Rosell-11.